Pre-clinical evaluation of antiviral activity of nitazoxanide against SARS-CoV-2 by Driouich, J-S, Cochin, M, Touret, F, Petit, P-R, Gilles, M, Moureau, G, Barthélémy, K, Laprie, C, Wattanakul, T, Chotsiri, P, Hoglund, RM, Tarning, J, Fraisse, L, Sjö, P, Mowbray, CE, Escudié, F, Scandale, I, Chatelain, E, de Lamballerie, X, Solas, C, Nougairède, A

Need for a standardized translational drug development platform: lessons learned from the repurposing of drugs for COVID-19 by Assmus, F, Driouich, J-S, Abdelnabi, R, Vangeel, L, Touret, F, Adehin, A, Chotsiri, P, Cochin, M, Foo, CS, Jochmans, D, Kim, S, Luciani, L, Moureau, G, Park, S, Pétit, P-R, Shum, D, Wattanakul, T, Weynand, B, Fraisse, L, Ioset, J-R, Mowbray, CE, Owen, A, Hoglund, RM, Tarning, J, Lamballerie, XD, Nougairède, A, Neyts, J, Sjö, P, Escudié, F, Scandale, I, Chatelain, E